For help on how to get the results you want, see our search tips.
8 results
Medicine type
Generic Remove Generic filter
Accelerated assessment Remove Accelerated assessment filter
Biosimilar Remove Biosimilar filter
Exceptional circumstances Remove Exceptional circumstances filter
Medicine
Summaries of opinion Remove Summaries of opinion filter
Withdrawn applications Remove Withdrawn applications filter
Referrals Remove Referrals filter
Application type
Initial authorisation Remove Initial authorisation filter
-
List item
Summary of opinion: Lextemy
bevacizumab, opinion date: 25/02/2021, Positive, Last updated: 26/02/2021 -
List item
Summary of opinion: Abiraterone Krka
abiraterone acetate, opinion date: 22/04/2021, Positive, Last updated: 23/04/2021 -
List item
Summary of opinion: Rivaroxaban Mylan
rivaroxaban, opinion date: 16/09/2021, Positive, Last updated: 17/09/2021 -
List item
Summary of opinion: Libmyris
adalimumab, opinion date: 16/09/2021, Positive, Last updated: 17/09/2021 -
List item
Summary of opinion: Sugammadex Mylan
sugammadex, opinion date: 16/09/2021, Positive, Last updated: 17/09/2021 -
List item
Summary of opinion: Hukyndra
adalimumab, opinion date: 16/09/2021, Positive, Last updated: 17/09/2021 -
List item
Summary of opinion: Imoxat (new)
imidacloprid, moxidectin, opinion date: 07/10/2021, Positive, Last updated: 08/10/2021 -
List item
Summary of opinion: Sitagliptin SUN (new)
sitagliptin fumarate, opinion date: 14/10/2021, Positive, Last updated: 15/10/2021